Artwork

Content provided by Dion Guagliardo. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dion Guagliardo or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

#65 Tony Keating - Co-Founder of ResApp

36:09
 
Share
 

Manage episode 409172883 series 3498379
Content provided by Dion Guagliardo. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dion Guagliardo or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

ResApp is a biotech company that commercialised technology to diagnose respiratory illnesses based on an audio recording of a patient’s cough on their phone. After proving immensely useful for diagnosing COVID-19 during the height of pandemic, Pfizer acquired the company for $180 million.

Throughout the episode, Tony discusses the path of listing on the ASX early-on and how that provided the initial capital needed for the company to succeed. Coming from a research background, Tony also talks about how his experience as a scholar and background in engineering contributes to being an effective CEO.

If you enjoy this episode, feel free to share with family and friends and leave a 5 star review.

Share the episode: https://thedionguagliardopodcast.buzzsprout.com/share
More on us!

Dion's Newsletter: http://eepurl.com/hHg1ff

Our social media: https://linktr.ee/FortressFinancial

Fortress Family Office: https://www.fortressfamilyoffice.com/

Contact us: admin@fortressfamilyoffice.com

  continue reading

70 episodes

Artwork
iconShare
 
Manage episode 409172883 series 3498379
Content provided by Dion Guagliardo. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dion Guagliardo or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

ResApp is a biotech company that commercialised technology to diagnose respiratory illnesses based on an audio recording of a patient’s cough on their phone. After proving immensely useful for diagnosing COVID-19 during the height of pandemic, Pfizer acquired the company for $180 million.

Throughout the episode, Tony discusses the path of listing on the ASX early-on and how that provided the initial capital needed for the company to succeed. Coming from a research background, Tony also talks about how his experience as a scholar and background in engineering contributes to being an effective CEO.

If you enjoy this episode, feel free to share with family and friends and leave a 5 star review.

Share the episode: https://thedionguagliardopodcast.buzzsprout.com/share
More on us!

Dion's Newsletter: http://eepurl.com/hHg1ff

Our social media: https://linktr.ee/FortressFinancial

Fortress Family Office: https://www.fortressfamilyoffice.com/

Contact us: admin@fortressfamilyoffice.com

  continue reading

70 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide